Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Less than 20% of patients with sensorineural hearing loss (HL) provided with the Vibrant Soundbridge (VSB) experience a progressive HL and warrant cochlear implantation (CI). The aim of this study was to identify possible predictors of progressive HL prior to VSB implantation. This retrospective study included all consecutive ears with sensorineural HL provided with the VSB between 1998 and 2016. The patient cohort was divided in a study group comprising patients who underwent CI (CI group) after years of VSB usage and those who did not require VSB replacement during the observational time (control group). Pre- and postoperative pure-tone audiometry thresholds were compared among the two groups. Fifteen out of 81 VSB devices (18.5%) required a CI. The CI group had higher preoperative air-conduction (AC) thresholds than the control group (64.3 ± 8.9 dB vs. 56.3 ± 12.9 dB; = 0.007) at the time of the VSB implantation. On average, the CI group was significantly younger (39.1 ± 12.3 years vs. 52.6 ± 16.2 years; = 0.003). In conclusion, VSB users with higher preoperative AC thresholds and younger age at the time of VSB implantation might be at risk for progressive HL within the upcoming eight years and need a further CI surgery. Preoperative counseling is particularly advisable in this patient group.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878649PMC
http://dx.doi.org/10.3390/jpm12020191DOI Listing

Publication Analysis

Top Keywords

vsb implantation
12
vsb
9
sensorineural hearing
8
hearing loss
8
vibrant soundbridge
8
cochlear implantation
8
control group
8
higher preoperative
8
time vsb
8
group
7

Similar Publications

Background: This prospective randomized study compares the efficacy of novel intravascular lithotripsy (IVL) to the standard preparation of calcified coronary lesions based on rotational atherectomy (RA).

Methods: A total of 50 patients with 52 calcified lesions were enrolled in the study and randomized 1:1 to be treated with IVL or RA followed by drug-eluting stent (DES) implantation. The procedural success was chosen as a primary endpoint and the 12-month late lumen loss (LLL) as measured by quantitative coronarography, the incidence of binary in-stent restenosis (ISR), 12-month major adverse cardiac events (MACE) and target lesion failure (TLF) served as secondary angiographic and clinical endpoints.

View Article and Find Full Text PDF

Introduction: There is limited evidence to guide treatment strategies for native and periprosthetic distal femoral nonunions. The aim was to determine factors associated with failure of distal femoral nonunion repair.

Methods: All adult patients undergoing operative repair for a distal femoral nonunion from 2004 to 2023 at two Level 1 Trauma Centers with ≥ 6 months follow-up were identified.

View Article and Find Full Text PDF

Objective: This study aimed to present and evaluate a surgical approach for placing a Vibrant Soundbridge® (VSB) device prior to auricular reconstruction in patients with microtia atresia. The goal was to determine whether an incision line for VSB implantation, located sufficiently posterior to the planned area of auricular reconstruction, could prevent interference with subsequent auricular surgeries and ensure stable hearing outcomes.

Methods: We retrospectively examined four patients with unilateral microtia who underwent VSB implantation before auricular reconstruction.

View Article and Find Full Text PDF

Objectives: To compare distal interlocking screw backout rates between two new-generation retrograde femoral nails: the DePuy Synthes RFN-Advanced Retrograde Femoral Nail (RFNA) and the Stryker T2 Alpha Femur Retrograde Nail (T2 Alpha).

Methods: Design : Retrospective comparative study.

Setting: Three Level 1 Trauma Centers.

View Article and Find Full Text PDF

Targeting ESKAPE pathogens with ZnS and Au@ZnS Core-Shell nanoconjugates for improved biofilm control.

Sci Rep

July 2025

Central Laboratory of The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, 323000, Zhejiang, China.

The escalating prevalence of antibiotic-resistant infections and implant-related complications caused by biofilm-forming pathogens from the ESKAPE group, as identified by the World Health Organization (WHO), underscores the urgent need for innovative anti-biofilm strategies. Their occurrence on medical implants & prosthetic devices, as well as nosocomial infections in co-morbid patients, has become a global concern in the healthcare sector. In response, we investigated the efficacy of as-synthesized ZnS quantum dots (ZnS QD) and novel Au@ZnS nanoconjugates (Au@ZnS NC) against a spectrum of ESKAPE pathogens.

View Article and Find Full Text PDF